BUZZ-Australia's Mayne Pharma rises on $10.3 million legal costs award

Maywood Acquisition Corp. 2 Class A

Maywood Acquisition Corp. 2 Class A

MYX

0.00

** Shares of Mayne Pharma Group MYX.AX rise as much as 6.8% to A$2.36, their largest intraday pct gain since May 28

** Pharma firm confirms it received a total of A$14.4 million ($10.26 million) from U.S.-based Cosette Pharmaceuticals in accordance with orders made by the Supreme Court of New South Wales

** Says amount comprises recovery of co's legal costs, costs associated with co's application and interest

** Mayne sued Cosette in June 2025 over its attempted termination of a February 2025 scheme deed, with a court ruling in October 2025 in Mayne's favour, dismissing all claims and ordering Cosette to pay costs

** Stock down 25.1% YTD, including the day's moves

($1 = 1.4037 Australian dollars)


This page is machine-translated. Sahm tries to improve but does not guarantee the accuracy and reliability of the translation, and will not be liable for any loss or damage caused by any inaccuracy or omission of the translation. *Disclaimer: The above content only represents the author's personal position and opinion and does not represent any position of Sahm Capital Financial Company and Sahm cannot confirm the authenticity, accuracy, and originality of the above content. Investors should consider the risks of investment products in light of their circumstances before making any investment decisions. When necessary, please consult a professional investment advisor. Sahm does not provide any investment advice, nor does it make any commitments and guarantees.